P1-251: Skin toxicities difference between erlotinib (E) and gefitinib (G) in the treatment of advanced non-small-cell lung cancer (NSCLC)

  • Francesco Grossi, Annalisa Brianti, Carlotta Defferrari, Maura Loprevite, Gianluca Catania, Maria Giovanna Dal Bello, Paolo Pronzato
  • Journal of Thoracic Oncology, August 2007, Elsevier
  • DOI: 10.1097/01.jto.0000284349.58716.73

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication


The following have contributed to this page: Dr Gianluca Catania